TOWARDS A HIGHER PERCENTAGE OF RECREATIONAL DRUGS-FREE AMONG PATIENTS ON METHADONE MAINTENANCE TREATMENT IN LARKIN HEALTH CLINIC
DOI:
https://doi.org/10.63719/qbulletin.v1i30.285Keywords:
Methadone Maintenance Treatment, Methadone, Recreational drugs, Illicit drugs use, Psychosocial intervention.Abstract
Methadone Maintenance Treatment (MMT) Clinic in Larkin Health Clinic was established in 2007 as part of Malaysia’s Harm Reduction Programme, mainly to prevent blood-borne viral infections, improve patients’ mental and physical health, improve their socio economics ability in society, and curb opiate addiction. A verification study in January 2017 found that only 34.9% of patients on MMT were recreational drugs-free after undergoing treatment. This study aimed to increase the percentage of recreational drugs-free among patients on MMT to 60% within one year. This quality improvement study was conducted among 63 patients and five healthcare providers. Face-to-face structured interviews with the respondents and brainstorming sessions with the healthcare providers were conducted to identify possible contributing factors. Four main contributing factors were identified; (i) healthcare workers were not formally trained for counselling techniques (100%), (ii) ineffective counselling (53%), (iii) unable to resist desire to take drugs (48%), and (iv) society’s negative views (45%). In the post-intervention phase, all contributing factors had improved except for two factors that were beyond the group intervention, which were easy access for patients to drug supplies (38%) and peer influence (38%). Strategies implemented include Psychosocial Intervention Strengthening Courses, FRAMES counselling techniques (Feedback, Responsibility, Advice, Menu of Options, Empathy, Self of efficacy), Metha Club establishment, group counselling, and reward system in Phase 1. Inter-agencies involvement was held in Phase 2 and reinforcement of spiritual elements was implemented in Phase 3. The Sustainability Phase strengthened the process of defaulter tracing and introduced a drug abuse legal awareness. At postintervention, the percentage of recreational drugs-free patients had increased from 34.9% (verification study) to 47.9% (Phase 1), 49.2% (Phase 2), 61.3% (Phase 3), followed by 65.1% (Sustainability Phase). ABNA reduced from 25.1% (Pre- Intervention) to -1.3% (Phase 3) and -5.1% (Sustainability Phase), thus the standard set in this study was successfully achieved.
References
1. National Anti-Drugs Agency. Drugs Statistics [Internet]. Available from: https://www.adk.gov.my/en/public/drugs-statistics/
2. Ali N, Aziz SA, Nordin S, Mi NC, Abdullah N, Paranthaman V, et al. Evaluation of Methadone Treatment in Malaysia: Findings from the Malaysian Methadone Treatment Outcome Study (MyTOS). Subst Use Misuse [Internet]. 2018;53(2):239–48. Available from: https://doi.org/10.1080/10826084.2017.1385630
3. Brownlie JM. Methadone replacement therapy. N Z Med J. 1972;75(480):312. Bahagian Perkhidmatan Farmasi Kementerian Kesihatan Malaysia. Direktori Perkhidmatan Farmasi Methadone Kementerian Kesihatan Malaysia. 2018.
4. Rohany Nasir, Fatimah Yusof, Zainah Ahmad Zamani MNMS. Kajian Pembinaan Generasi Muda. 2006.
5. Nasir R, Yusooff F, Ahmad Zamani Z, Mohamed Sani M. Kajian pembinaan modul untuk mencegah penyalahgunaan dadah dikalangan generasi muda [Internet]. 2006 p. 1-60. Available from: http://www.iyres.gov.my/jdownloads/Penyelidikan/kajianpembinaan-modul- untuk-mencegahpenyalahgunaan-dadah-dikalangangenerasi-muda.pdf
6. Kreek MJ, Borg L, Ducat E, Ray B. Pharmacotherapy in the treatment of addiction: Methadone. J Addict Dis. 2010;29(2):200–16.
7. Almeman AA, Ismail R, Mohamad N. Methadone Maintenance Therapy (MMT) in Malaysia: An observational clinical study. Australas Med J. 2017;10(4):314–21.
8. Metrebian N, Weaver T, Pilling S, Hellier J, Byford S, Shearer J, et al. Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency management. Contemp Clin Trials. 2018;71(March):124–32.
9. Veilleux JC, Colvin PJ, Anderson J, York C, Heinz AJ. A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction. Clin Psychol Rev [Internet]. 2010;30(2):155–66. Available from: http://dx.doi.org/10.1016/j.cpr.2009.10.006
10. Lo A, Kerr T, Hayashi K, Milloy M-J, Nosova E, Liu Y, et al. Factors associated with methadone maintenance therapy discontinuation among people who inject drugs. J Subst Abuse Treat [Internet]. 2018 Nov;94(3):41–6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375706/pdf/nihms-1010831.pdf
11. History PP. Methadone-Drug Interactions. 2010;1997(January 2006):2006–10.
12. Azmi AA, Hussin H, Ishak SIDi, Daud-Fhiri NS. Drug Addicts: Psychosocial Factor
Contributing to Relapse. MATEC Web Conf. 2018;150:1–6.
13. Min Z, Xu L, Chen H, Ding X, Yi Z, Mingyuang Z. A pilot assessment of relapse prevention for heroin addicts in a Chinese rehabilitation center. Am J Drug Alcohol Abuse. 2011;37(3):141–7.
14. Larimer ME, Palmer RS, Alan Marlatt G. Relapse prevention an overview of Marlatt’s cognitive-behavioral model. Psychosoc Treat. 2003;23(2):1–17.
15. Bourne PG. Non Pharmacological Approach to Treatment Drug Abuse. pdf. The American Journal of Chinese Medicine; 1975. p. Volume 03, Issue 03 pp. 235-244.
16. UNICEF. Laporan Tahunan. Bul Jendela Data dan Inf Kesehat. 2013;29–33.


